Why Is Summit Therapeutics Inc. (NASDAQ: SMMT) Stock Up Today?

Summit Therapeutics Inc. (NASDAQ: SMMT) Summary

Summit Therapeutics Inc. (NASDAQ: SMMT) is trading down -1.67% at $13.53, reflecting a negative shift in investor sentiment today. The stock opened at $13.91 and has moved between $13.44 and $13.96 so far.

Trading volume is 1986033, which is 60% below its average, and the price action suggests selling interest.

Technically, SMMT on the NASDAQ is trading below its 50-day moving average of $14.68 and below its 200-day moving average of $17.01, indicating short-term and long-term weakness.

Analyst sentiment is bullish. Meyka's AI assigns SMMT a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of -18.03% in 1 month ($11.09), +7.42% in 1 year ($14.53), and -100.00% in 5 years ($0.00).

See full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement on the NASDAQ.
Stay informed and make better investment decisions.